Syntis Bio Inc
Publicly observedBoston, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Boston | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Syntis Bio Inc | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | NG1VDVGBHC87 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant17 Sept 2025Publicly observed
NIH SBIR/STTR award: Development of an Oral Methionine-Gamma-Lyase Enzyme for the Treatment of Homocystinuria
USD 347,016.00 · Eunice Kennedy Shriver National Institute of Child Health and Human Development · Source: NIH RePORTER (opens in a new tab)
- Grant10 Sept 2025Publicly observed
NIH SBIR/STTR award: Development of Once-daily Oral Treatment for Maple Syrup Urine Disease
USD 343,635.00 · National Institute of Diabetes and Digestive and Kidney Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant1 Aug 2025Publicly observed
NIH SBIR/STTR award: Oral Therapeutics Platform for Treating Inborn Errors of Amino Acid Metabolism
USD 324,984.00 · National Institute of Diabetes and Digestive and Kidney Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant15 Sept 2024Publicly observed
NIH SBIR/STTR award: Development of an Oral Pill to Mimic the Effects of Gastric Bypass Surgery
USD 916,664.00 · National Institute of Diabetes and Digestive and Kidney Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant15 Sept 2024Publicly observed
NIH SBIR/STTR award: Development of an Oral Pill to Mimic the Effects of Gastric Bypass Surgery
USD 916,400.00 · National Institute of Diabetes and Digestive and Kidney Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant1 May 2024Publicly observed
NIH SBIR/STTR award: Polymer Epithelial Lining for the Oral Delivery of Macromolecules
USD 1,190,375.00 · National Institute of Diabetes and Digestive and Kidney Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant1 May 2024Publicly observed
NIH SBIR/STTR award: Polymer Epithelial Lining for the Oral Delivery of Macromolecules
USD 1,245,529.00 · National Institute of Diabetes and Digestive and Kidney Diseases · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.